Oral contraceptives and hypertension

Oral Contraceptives And Hypertension

The contraceptive pill contains a mixture of estrogen and progestin, but in the formulations currently in use, the amount of each ingredient is lower than the initial dose, although there is considerable variation among pill brands. The risk of hypertension while taking oral contraceptives has been studied by nurses in the medical literature.

Reports of hypertension associated with the use of oral contraceptives began to appear after the pill was introduced to the market more than 30 years ago.

Birth control pills contain a mixture of estrogen and progestin, but in the formulations currently in use, the amount of each ingredient is lower than the initial dose, although there are significant differences between brands of birth control pills. Studies in the medical literature have examined the risk of developing or developing hypertension when nurses take oral contraceptives.

Birth control pills contain both estrogen and progestin, but in the formulations currently in use, the levels of each ingredient are lower than the initial dose, although there are differences between different brands of birth control pills. The risk of hypertension in nurses taking oral contraceptives has been studied in the medical literature.

Reports of hypertension associated with the use of oral contraceptives began to appear more than 30 years ago, when the pill became available.

Birth control pills contain a mixture of estrogen and progestin, but in the formulations currently in use, the dosage of each ingredient is less than the initial dose, although there are differences between brands. In the medical literature, there is a study on the risk of developing or developing high blood pressure when nurses take oral contraceptives.

The study was based on a study that tracked the health status of more than 110,000 U.S. nurses. Among other questions, they were asked about their use of oral contraceptives and blood pressure on three occasions over a four-year period. Women who reported high blood pressure at the start of the study were excluded from this analysis.

Women who used oral contraceptives were 80% more likely to develop hypertension than women who did not use oral contraceptives. This risk was higher in women who had used the pill for more than 6 years. There was no significant difference in risk depending on the amount of estrogen and progestin in the pills.

Women with a family history of hypertension had a higher risk of developing the condition but were less sensitive to the effects of oral contraceptives than women without a family history. The number of women who develop hypertension after taking the pill is small, equating to 41 cases per 10,000 people, or 0.4% per year.

This study is reassuring for women taking the pill because although there is a risk of developing hypertension, the risk is low. In addition, other studies have shown that if blood pressure is elevated, it usually falls after three months off the pill.

Hypertension produced by these compounds is usually mild and depends on the concentration of the drug. High doses of estrogens, estradiol, and synthetic progestins all produce a 5-18% incidence of hypertension, with the exception of estrogens at daily doses between 50 ng and 100 ng, which fall below 5% for estradiol at doses below 50 ng per day. The detection rate is higher in patients with hypertension.